π¨ My usual account has been hacked. I'm sure that is completely obvious to anyone looking at it.
@X refuses to fix it, saying they cannot verify that I am the owner. So much for the power of AI @grok
@X please restore this account to its rightful owner. The community relies on Tyler for education and for sharing his excellent work.
@grok any idea why @X hasnβt restored it yet? It seems obvious that @TylerSbrt was hacked. Do we need a petition or something to get this fixed?
π¨ My usual account has been hacked. I'm sure that is completely obvious to anyone looking at it.
@X refuses to fix it, saying they cannot verify that I am the owner. So much for the power of AI @grok
π¨ My usual account has been hacked. I'm sure that is completely obvious to anyone looking at it.
@X refuses to fix it, saying they cannot verify that I am the owner. So much for the power of AI @grok
Indeed, including those open at MSKCC where we accrue perhaps 122 patients per year. Cancer RCTs accrue slowly because they are too complex, too burdensome for patients & MDs, & don't address the reasons why patients don't go on trials (& why MDs don't approach them for consent)
Congratulations @MontefioreD & team ππ½ I remember talking to you in clinic about this as a registrar. Great to see the results and the impact for patients #ESTRO25@ESTRO_RT@TheLancetOncol
π’ STORM trial breaking results at #ESTRO25!
π§ͺ MDT vs ENRT MDT for nodal oligorecurrent PCa.
𧬠ENRT MDT:
β Superior bRFS (57% vs 41%, p=0.014)
β Superior pelvic control (lrRFS 85% vs 62%, p=0.006)
β Superior MFS (76% vs 63%, p=0.06)
β No increase in β₯G2 GU/GI toxicity